Understand the Environment
Making Market Access Real
Launch Excellence: Driving Access and Innovation in the NHS
This session focuses on how pharmaceutical companies can better align with the NHS to ensure successful product launches. It introduces the three core pillars of Launch Excellence.
Population Health and the Role of Life Sciences
Population Health and the role of Life Sciences can play in effective collaboration with the NHS with Dr Matt Kearney OBE, CEO, Into-Action. Health, Founder CVDACTION, CVDPREVENT and Proactive Care Frameworks and Adam Chapman, Head of Population Health, AstraZeneca.
Navigating Rare Disease Policy Landscape
The shift from sickness to prevention, especially in the context of early diagnosis and treatment, can have a significant impact on patients, families, and healthcare systems. As we navigate these changes, it's crucial that rare diseases are not forgotten and are included in the broader healthcare discussions. Looking forward to seeing how we can continue to advocate for rare diseases in the evolving healthcare landscape.
Related Solutions
Quantify the Opportunity
Transform the Pathway
Identify the Patient
Implement the Change
Support the Patient
